Expertise in
32
conditions

Dr. Christopher M. Mccanless

Oncology
Hematology/Oncology Clinic
8595 Picardy Ave Ste 400, 
Baton Rouge, LA 
Accepting New Patients
Expertise in
32
conditions
Hematology/Oncology Clinic
8595 Picardy Ave Ste 400, 
Baton Rouge, LA 

Overview

Christopher Mccanless is an Oncologist practicing medicine in Baton Rouge, Louisiana.

Dr. Mccanless is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Paget Disease of the Breast, Familial Colorectal Cancer, Bone Marrow Aspiration, and Endoscopy.

He is actively involved in clinical research, participating in 3 clinical trials. Dr. Mccanless is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in LA

Hospital Affiliations

Baton Rouge General Medical Center
Womans Hospital
Our Lady Of The Lake Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Hematology/Oncology Clinic
8595 Picardy Ave Ste 400, Baton Rouge, LA 70809

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients With Locally Advanced or Metastatic Solid Tumors That Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements
An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients With Locally Advanced or Metastatic Solid Tumors That Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements
Enrollment Status: Active_not_recruiting
Publish Date: August 25, 2026
Intervention Type: Drug
Study Drug: Entrectinib
Study Phase: Phase 2
postMONARCH: A Randomized, Double Blind, Placebo-Controlled, Phase 3 Study to Compare the Efficacy of Abemaciclib Plus Fulvestrant to Placebo Plus Fulvestrant in Participants With HR+, HER2-, Advanced or Metastatic Breast Cancer Following Progression on a CDK4 & 6 Inhibitor and Endocrine Therapy
postMONARCH: A Randomized, Double Blind, Placebo-Controlled, Phase 3 Study to Compare the Efficacy of Abemaciclib Plus Fulvestrant to Placebo Plus Fulvestrant in Participants With HR+, HER2-, Advanced or Metastatic Breast Cancer Following Progression on a CDK4 & 6 Inhibitor and Endocrine Therapy
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Fulvestrant
Study Phase: Phase 3
A Randomized Phase III Trial of OSE2101 Compared With Chemotherapy (Docetaxel or Pemetrexed) in HLA-A2 Positive Patients With Advanced Non-Small Cell Lung Cancer With Progressive Disease After Immune Checkpoint Inhibitors
A Randomized Phase III Trial of OSE2101 Compared With Chemotherapy (Docetaxel or Pemetrexed) in HLA-A2 Positive Patients With Advanced Non-Small Cell Lung Cancer With Progressive Disease After Immune Checkpoint Inhibitors
Enrollment Status: Terminated
Publish Date: February 02, 2024
Intervention Type: Drug, Biological
Study Drugs: OSE2101, Docetaxel, Pemetrexed
Study Phase: Phase 3
View 2 Less Clinical Trials
Similar Doctors
Expertise in
55
conditions
Dr. Siva Sankar-Yadlapati
Hematology | Oncology
Expertise in
55
conditions
Dr. Siva Sankar-Yadlapati
Hematology | Oncology
Referral may be required

Hematology Oncology Associates Of Baton Rouge

4950 Essen Ln, 
Baton Rouge, LA 
 (2.1 miles away)
225-767-0847
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Siva Sankar-Yadlapati is a Hematologist and an Oncologist practicing medicine in Baton Rouge, Louisiana. Dr. Sankar-Yadlapati is highly rated in 55 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Sickle Cell Disease, Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration. Dr. Sankar-Yadlapati is currently accepting new patients.

Expertise in
46
conditions
Expertise in
46
conditions
Referral may be required

Our Lady Of The Lake Physician Group LLC

7777 Hennessy Blvd Ste 6000, 
Baton Rouge, LA 
 (2.4 miles away)
225-757-0343
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Greg Bizette is an Oncologist practicing medicine in Baton Rouge, Louisiana. Dr. Bizette is highly rated in 46 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Colorectal Cancer, Adult Soft Tissue Sarcoma, and Bone Marrow Aspiration. Dr. Bizette is currently accepting new patients.

Expertise in
8
conditions
Expertise in
8
conditions
Referral may be required

Shaista H. Faruqui M.D. Apmc

5320 Dijon Dr, 
Baton Rouge, LA 
 (2.5 miles away)
225-769-2161
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Shaista Faruqui is an Oncologist practicing medicine in Baton Rouge, Louisiana. Dr. Faruqui is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Chronic Familial Neutropenia, Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, and Agranulocytosis. Dr. Faruqui is currently accepting new patients.

Frequently Asked Questions about Dr. Christopher M. Mccanless

How do I make an appointment with Dr. Christopher M. Mccanless?

You can book an appointment with Dr. Christopher M. Mccanless by calling their office at 225-767-0822. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Christopher M. Mccanless a top-rated expert for Neuroendocrine Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christopher M. Mccanless is classified as an Distinguished expert for Neuroendocrine Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Christopher M. Mccanless specialize in?

While Dr. Christopher M. Mccanless is a Oncology, they have specific expertise in Neuroendocrine Tumor, Paget Disease of the Breast, and Familial Colorectal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Christopher M. Mccanless accept my insurance?

Dr. Christopher M. Mccanless accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 225-767-0822 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mccanless's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 24 Advanced Conditions
    View All 98 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile